As of March 23, 2026, the three largest insider holders of IMVT are Sciences Ltd. Roivant (Director, 113.32Mn shares), Peter Salzmann (Chief Executive Officer, 1.18Mn shares), Frank Torti (Director, 835.04K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Sciences Ltd. Roivant | 113,317,007 | 0 | 12 Dec, 2025 | |
| Peter Salzmann | Chief Executive Officer | 1,178,191 | 0 | 17 Apr, 2025 |
| Frank Torti | 835,039 | 0 | 03 Apr, 2025 | |
| William L. Macias | Chief Medical Officer | 357,353 | 0 | 21 Feb, 2025 |
| Mark S. Levine | Chief Legal Officer | 319,228 | 0 | 22 Nov, 2024 |
| Jay S Stout | Chief Technology Officer | 197,634 | 0 | 23 Jan, 2026 |
| Tuyl Christopher Van | Chief Legal Officer | 147,053 | 0 | 20 Mar, 2026 |
| George V Migausky | 137,251 | 0 | 03 Apr, 2025 | |
| Atul Pande | 102,851 | 0 | 03 Apr, 2025 | |
| Robert Graham Susman | 25,016 | 0 | 05 May, 2025 | |
| Atul Pande | 0 | 20,000 | 04 Oct, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 18 Mar, 2026 | Tuyl Christopher Van | Common Stock | D | 2,877 | $24.97 | 147,053 | D | S |
| 21 Jan, 2026 | Jay S Stout | Common Stock | D | 1,977 | $26.03 | 197,634 | D | S |
| 07 Jan, 2026 | Jay S Stout | Common Stock | D | 1,148 | $26.51 | 199,666 | D | S |
| 07 Jan, 2026 | Jay S Stout | Common Stock | D | 55 | $26.92 | 199,611 | D | S |
| 18 Dec, 2025 | Tuyl Christopher Van | Common Stock | D | 8,529 | $26.78 | 152,214 | D | S |
| 18 Dec, 2025 | Tuyl Christopher Van | Common Stock | D | 2,284 | $27.38 | 149,930 | D | S |
| 12 Dec, 2025 | Sciences Ltd. Roivant | Common Stock, $0.0001 par value per share | A | 16,666,666 | $21.00 | 113,317,007 | D | P |
| 22 Oct, 2025 | Jay S Stout | Common Stock | D | 2,520 | $19.03 | 200,814 | D | S |
| 08 Oct, 2025 | Jay S Stout | Common Stock | D | 1,585 | $16.30 | 203,334 | D | S |
| 28 Jul, 2025 | Eric Venker | Stock Option (right to buy) | A | 1,300,000 | $0.00 | 1,300,000 | D | A |
| 28 Jul, 2025 | Eric Venker | Stock Option (right to buy) | A | 189,900 | $0.00 | 189,900 | D | A |
| 28 Jul, 2025 | Eric Venker | Capped Value Appreciation Rights | A | 1,475,000 | $0.00 | 1,475,000 | D | A |
| 23 Jul, 2025 | Jay S Stout | Common Stock | D | 2,805 | $18.15 | 204,919 | D | S |
| 09 Jul, 2025 | Jay S Stout | Common Stock | D | 1,519 | $17.24 | 207,724 | D | S |
| 01 May, 2025 | Robert Graham Susman | Common Stock | A | 25,016 | $0.00 | 25,016 | D | A |
| 01 May, 2025 | Robert Graham Susman | Stock Option (Right to Buy) | A | 35,234 | $0.00 | 35,234 | D | A |
| 23 Apr, 2025 | Jay S Stout | Common Stock | D | 1,925 | $14.79 | 209,243 | D | S |
| 16 Apr, 2025 | Peter Salzmann | Common Stock | D | 8,321 | $14.89 | 1,178,191 | D | S |
| 09 Apr, 2025 | Jay S Stout | Common Stock | D | 5,004 | $12.99 | 211,168 | D | S |
| 09 Apr, 2025 | Peter Salzmann | Common Stock | D | 28,094 | $12.99 | 1,186,512 | D | S |